Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03BZN
|
||||
Former ID |
DIB002059
|
||||
Drug Name |
Sodium taurocholate
|
||||
Synonyms |
Sodium taurocholate (rectal gel, diabetes/ obesity)
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Phase 1/2 | [551663] | ||
Company |
Satiogen Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C26H44NNaO7S
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | TGR5 | Target Info | Modulator | [551663] | |
WikiPathways | GPCR ligand binding | ||||
GPCR downstream signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.